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Summary Human gastric carcinomas were tested for their immunohistochemical reactivity with anti-type I
procollagen antiserum. In all specimens of scirrhous carcinomas, staining of the tumour cells was strongly
positive, while in medullary carcinomas staining of the tumour cells was generally poor. These results suggest
that the tumour cells in scirrhous carcinomas produce collagen in their stroma.
Scirrhous carcinoma of the stomach is characterized by
extensive fibrosis with sparse tumour cell infiltration in
desmoplastic stroma, and clinically by the worst prognosis of
any type of gastric cancer. The fibrous stroma is composed
mainly of type I and type III collagens (Kohda et al., 1984;
Nagi et al., 1985). Both of these are found in most normal
connective tissues, but type I is more prevalent. Generally,
mesenchymal cells are responsible for the synthesis and
deposition of collagen in connective tissues. In an attempt to
determine which cell types are responsible for the synthesis
of collagen in tissue of scirrhous carcinoma, the immuno-
histochemical localization of procollagen type I, a precursor
form ofcollagen type I, was investigated.
Materials and methods
Purification oftype Iprocollagen
Normal human lung fibroblasts (IMR90) (Uitto et al., 1976)
in the 20-30th generation with 3rd-5th passage, were grown
at 37°C in culture flasks, (T75, T 150; Corning) or roller
bottles (area 490cm2, Corning), in Dulbecco's modified
Eagle medium (DMEM, Grand Island Biological),
supplemented with 10% foetal calf serum and 50pgml-1
Geramycin (Schering). When the cells reached the early
confluence they were washed 3 times with PBS and cultured
another 24h in serum-free DMEM containing ascorbate
(75pgml-1) and L(2,3)3H-proline (20-40Cimmol-1, New
England Nuclear) 4pCiml -1. The serum-free medium (-. 11)
was then collected and cooled on ice, and to it were added
various protease inhibitors (Uitto et al., 1976) to give the
following final concentrations: 25mm disodium ethylene
diaminetetraacetate (EDTA, Baker); 10mm N-ethylmaleimide
(NEM, Sigma); 1.0mm phenylmethylsulfonyl-fluoride
(PMSF, Sigma) and 1 mm p-aminobenzamide-HCI (Sigma).
Proteins in the medium were precipitated by adding
176mgml-1 ammonium sulphate (Baker) with stirring over-
night at 4°C. The precipitate was centrifuged at 30,000g for
30min to remove supernatant. The pellet was then dissolved
in 20ml of ice-cold of 0.1 M Tris HCI buffer containing 0.4M
NaCl, pH7.5, and was centrifuged at 30,000g for 30min.
The supernatant was dialyzed against 0.1 M Tris HCI buffer,
pH7.8, containing 2M urea, 2.5mm EDTA (starting buffer
A) at 4°C for overnight, prior to the application to a DEAE
Sephacel column (1.6 x 1Ocm) which had been equilibrated
with the starting buffer A.
Chromatography was carried out with a linear salt
gradient prepared with 150ml of the starting buffer A and
equal amounts of the same buffer containing 0.2M NaCl.
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Small portions (200 ul) of each fraction (2.5ml) from the
column were mixed with Hydrofluor (National Diagnostics)
and counted in a Searle Mark III liquid scintillation counter.
The peak with the highest radioactivity, eluting at 0.05M
NaCl, was collected and dialyzed against 0.1 M Tris HCI
buffer, pH7.5, containing 0.4M CaCl2.
Preparation ofcollagenfrom procollagen (type I)
Purified procollagen (1 mg) was dialyzed 0.1N acetic acid
and was incubated with pepsin (100pgml 1) at 4°C for 15h.
The pepsin was then inactivated by dialyzing the sample
against 0.4M NaCl in 0.1M Tris HCI buffer, pH7.5 at 4°C,
and salted out with 176mgml-1 ammonium sulphate. After
centrifugation at 30,000g for 30min, the pellet was recovered
and dialyzed against 0.04M sodium acetate buffer, pH4.8,
containing 1 M urea (starting buffer B). Five mg of rat skin
type I collagen (gift from Dr George Wu, University of
Connecticut) prepared by pepsin digestion at 4°C was mixed
with the sample as a carrier. The samples were dialyzed
against the starting buffer B at 4°C and then heated for
15min at 55°C just prior to chromatography. Chroma-
tography was carried out on a 1.4 x 7cm column of CM-
cellulose (CM 52, Whatman) (Uitto et al., 1976) with a linear
gradient prepared with 100ml of starting buffer B and
100ml of the same buffer containing 0.1 M NaCl, at a
temperature of 45°C. Two ml fractions were collected and
absorbance was measured at 232nm. The radioactivity of
each fraction was measured as described above.
Preparation and testing ofantisera to type I collagen
Purified procollagen (0.5mg) suspended in 0.5ml of 0.1M
Tris HCI buffer, pH7.5, containing 0.15M NaCl was
thoroughly mixed with 0.5ml Freund's complete adjuvant.
This emulsion was injected i.d. into multiple sites of the
dorsal skin of male albino rabbits (- 2kg). Booster
injections were given at intervals of 2-3 days, the animals
were bled and serum collected. Immunodiffusion was carried
out in 1% agarose containing 0.85% NaCl. After incubation
at 37°C for 2 days, the plates were washed with PBS and
then dried at room temperature. The dried plates were
stained with amido black 1OB solution.
Sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE)
Gel electrophoresis was performed in 5%, 7.5% or 10% gels
as described previously (Maizel, 1971). Samples were reduced
with 5% mercaptoethanol or 50mM dithiothreitol in 1%
sodium dodecyl sulphate at 55°C for 30min prior to
application to gels. In some experiments, samples were
alkylated with 150mm iodoacetic acid after reduction with
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50mM dithiothreitol. After electrophoresis, gels were stained
with coomassie brilliant blue.
Immunohistochemical staining
Fresh specimens of stomach cancer tissue were obtained
surgically. Immunoperoxidase staining was essentially by the
avidin-biotin-peroxidase complex (Hsu et al., 1981). Internal
(endogenous) peroxidase activity was blocked by exposing
the specimens to a 0.6% solution of hydrogen peroxide in
absolute methanol prior to staining.
Results
SDS-PAGE oftype Iprocollagen
Human type I procollagen obtained from culture medium of
IMR90 fibroblasts was examined for its purity on SDS-
PAGE (Figure 1). The purified procollagen showed a single
band at the top of the gel (lane 2); this was converted by
reduction into 2 distinct bands with mol. wts of 150,000 and
120,000, corresponding to pro al and pro a2 chains
respectively. Densitometric scanning revealed that the
intensity of pro al band was approximately twice that of pro
a2 band, indicating that the procollagen consisted of two pro
al chains and one pro a2 chain, characteristic of type I
procollagen.
CM-cellulose chromatography and SDS-PAGE of
pepsin-digested type Iprocollagen
In order to confirm that the purified procollagen was indeed
type I species, its collagen portion prepared by digestion with
pepsin was analysed by SDS-PAGE and chromatography on
a CM-cellulose column. As shown in Figure 1, pepsin
digested procollagen (lane 4) and its reduced preparation
(lane 5) were both separated into 2 bands, apparently
corresponding to the al and a2 chains of rat skin type I
collagen (lane 1). CM-cellulose chromatography of pepsin
digested type I procollagen which was incorporated with 3H
proline also revealed a typical elution profile of al and a2
chains of type I collagen with no contamination with chains
of type III collagen, since only two peaks of radioactivity
coinciding to those of rat skin type I collagen (internal
standard) were observed (Figure 2).
Immunoreactivity ofanti-type Iprocollagen antiserum
Immunoreactivity of anti-type I procollagen antiserum, with
type I procollagen, collagenase-treated type I procollagen,
and pepsin-treated type I procollagen was investigated by
double immunodiffusion (Figure 3). The antiserum precipi-
tated type I procollagen and collagenase-treated procollagen,
but not pepsin-treated procollagen, indicating that the
antiserum recognizes the non-collagenous portion
(procollagen peptide) of the procollagen molecule.
Histological classification ofstomach cancer
Histological classification of stomach cancer was based on
The General Rules for the Study of Gastric Cancer in
Surgery and Pathology (Nagayo et al., 1979).
Immunohistochemical staining ofstomach carcinoma with
anti-type Iprocollagen antiserum
A typical tissue specimen of scirrhous carcinoma of the
stomach was stained with type I procollagen antiserum
(Figure 4A). The figure shows that both fibroblasts and
tumour cells were clearly stained.
The positive staining was not due to technical artifacts,
since the intensity was weakened substantially when the
staining was performed with rabbit serum containing the
antigen (Figure 4B). Staining was negative for tumour cells
and fibroblasts in the control specimen which was treated
with normal rabbit serum (Figure 4C).
On the basis of these observations, 9 surgical specimens of
stomach carcinoma of various histological types were
examined for their immunoreactivity with type I procollagen
antiserum. Figure 5 shows the immunohistochemical staining
patterns for these sections, and the data obtained are
analyzed and summarized in Table I. For specimens of the
four Borrmann type IV carcinomas and one of Borrmann
type III carcinomas, all of which exhibited abundant fibrous
stroma (histologically scirrhous), the cytoplasm of the
tumour cells was strongly positive. In contrast, the tumour
cells of the non-scirrhous carcinoma (histologically medul-
lary) were poorly reactive to type I procollagen antiserum. In
all of the histological types tested, the fibroblasts in the
stroma stained positively although with a weaker intensity
than that observed with the scirrhous carcinoma cells.
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Figure 1 SDS-PAGE of purified type I procollagen and its pepsin-digested preparation. A single and discrete band at the top of
the gel was observed in purified type I procollagen (lane 2), which was separated into two bands of pro al and pro a2 chains by
reduction and alkylation (lane 3). Pepsin-digested type I procollagen (lane 4) and its reduced form (lane 5) both showed two bands
corresponding to a, and a2 chains of rat skin type I collagen (lane 1).TYPE I PROCOLLAGEN IN GASTRIC CARCINOMA 81
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Figure 2 CM-cellulose chromatography of pepsin-digested type
I procollagen. Two peaks of radioactivity coinciding to those of
rat skin type I collagen (O 0) were observed in the prepara-
tion of pepsin-digested 3H type I procollagen (0 0).
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Figure 3 Double immunodiffusion between anti-type I pro-
collagen antiserum and collagenase- or pepsin-treated type I
procollagen. Both type I procollagen (A) and bacterial
collagenase-treated type I procollagen (B) formed sharp
precipitin lines with complete fusion against anti-type I pro-
collagen antiserum (ab), while pepsin-treated type I procollagen
(C) was not immunologically reactive with the same antiserum.
In fibrous stroma, positive staining was not observed in all
specimens, possibly reflecting the fact that secreted
procollagen is water soluble and does deposit in the tissue.
Discussion
In scirrhous carcinoma, there have been divergent opinions
for some time whether the mechanism of collagen increase in
the tumour is due to primary production by the tumour cells
(Sakakibara et al., 1982; Takeuchi, 1976; Roesel et al., 1978;
Al-Adnani et al., 1975) or to secondary production by
tumour-stimulated fibroblasts (Naito et al., 1984; Yamamoto
et al., 1984).
In the present study, we investigated the origin of the
collagen in stomach carcinoma by immunohistochemical
means employing an antibody to procollagen. Strong
staining was observed in the cytoplasm of scirrhous
carcinoma cells, while little or none was observed in non-
scirrhous carcinoma cells. Because the antibody used in this
study is one that does not react with collagen but only with
procollagen, the immunohistochemically positive result
indicates that pronounced synthesis of the collagen precursor
occurs at the site of the staining. Thus in scirrhous
carcinoma of the stomach, the carcinoma cells are a major
producer of collagen, although fibroblasts also engage in
collagen synthesis. The latter is affirmed by the fact that
Figure 4 Immunohistochemical specificity of anti-type I pro-
collagen antiserum. A surgical specimen of stomach carcinoma
(scirrhous type) was examined by avidin-biotin-peroxidase
complex method. The specimen was stained with (A) anti-type I
procollagen rabbit serum (1:50 dilution was PBS), (B) the same
antiserum absorbed with the antigen, and (C) normal rabbit
serum. Note that only (A) specimen was positively stained
(Bar =50 pm).
fibroblasts in the same tissue also stained to a comparable
extent.
It should be noted that type III as well as type I collagen
is known to increase in scirrhous carcinoma tissue (Kohda et
al., 1984; Nagai et al., 1985). The antibody used in this study
specifically recognized only type I, and thus the question of
the cellular origin of type III collagen is not addressed here.
Since the number of cases studied was limited, it is
premature to conclude that the observation with respect to
type I procollagen in this study will be found in all cases of
scirrhous stomach carcinoma. Clearly, however, at least a
proportion of the increased collagen content in scirrhous
carcinoma is due to production by tumour cells. And these
observations are compatible with our recent unpublished
findings that tumour cells established from scirrhous
carcinoma express procollagen type I mRNA as revealed by
northern blot hybridization.
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Figure 5 Immunoperoxidase staining of type I procollagen in 9 stomach carcinomas of various histological types. Cytoplasm of
the tumour cells was strongly stained in specimens of scirrhous type (1-5) while in specimens of medullary type (6-9) very weak
staining, if any, was observed of tumour cells. (Bar=50!Lm).
Table I Comparison of intensity of immunoperoxidase staining for type I procollagen in nine gastric carcinomas of
various histological types
Classification on the Intensity ofstaining (- + +)
Case Borrmann Histological basis ofthe relative
no. classification diagnosis amount offibrous septa Cancer cells Fibroblasts
I IV poorly diff. adeno ca. scirrhous type + + +
2 IV poorly diff. adeno ca. scirrhous type + + +
3 IV poorly diff. adeno ca. scirrhous type + + +
4 IV poorly diff. adeno ca. scirrhous type + + +
5 III poorly diff. adeno ca. scirrhous type + + + +
6 III poorly diff. adeno ca. medullary type + +
7 III poorly diff. adeno ca. medullary type + +
8 III moderately diff. medullary type _ +
tubular adeno ca.
9 III papillary adeno ca. medullary type + +
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